Platform coming soon.
Treatment intelligence for precision specialty care
Evidara turns longitudinal, multimodal patient data into patient-specific predictions of treatment outcomes for each therapeutic option.
Partner with usOur mission
Patients with the same diagnosis differ in treatment outcomes. Yet, specialty medicine runs on population averages, with limited ability to personalize treatment decisions.
Our objective is to transform multimodal data into AI-powered intelligence that delivers personalized treatment pathways for every patient, at every visit, across specialty conditions.
We aim to provide actionable insights that inform therapy selection and ongoing disease management — improving clinical outcomes and the economics of care.
Every major treatment decision can be informed by a prediction of how that individual patient is likely to respond. Evidara is building the infrastructure to make that possible across specialty medicine.
Starting with ophthalmology
We are leveraging the power of computational data science to move from reactive treatment adjustment to proactive disease management and help preserve vision across prevalent eye conditions.
Rich multimodal data
Longitudinal imaging and EHR, combined with objective clinical outcomes.
Treatment every 4–16+ weeks creates repeated opportunities to learn from individual treatment responses.
A diverse therapeutic landscape spanning anti-VEGF agents, corticosteroids, sustained-release implants, complement inhibitors, and emerging therapies.
Measurable outcomes
Anatomical and functional response, treatment durability, long-term visual outcomes, and treatment burden can be observed over time.
One intelligence layer, value across healthcare
Providers
Personalized treatment decisions that drive clinical, economic, and operational value.
Payers
Identify high-value therapies and inform evidence-based coverage and treatment policies.
Pharma
Multimodal, imaging-rich data insights for biomarker intelligence and real-world evidence.
Roadmap
- In development
Ophthalmology
Building treatment-response intelligence across eye diseases from longitudinal, multi-institutional data.
- Coming soon
Deployment
Bringing patient-specific predictions to clinical workflows, payers, and life-science research.
- On the horizon
Specialty expansion
Extending the platform to additional specialty conditions where treatment choices are complex and costly.
Contact us
Our platform is in development. Provide a few details and we’ll be in touch soon.